Literature DB >> 22869847

Mechanism of action of DPP-4 inhibitors--new insights.

Adrian Vella.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22869847      PMCID： PMC3410278          DOI： 10.1210/jc.2012-2396

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  19 in total

Review 1.  The glucagon-like peptides.

Authors:  T J Kieffer; J F Habener
Journal:  Endocr Rev       Date:  1999-12       Impact factor: 19.871

2.  Glucagon-like peptide-1 mediates the therapeutic actions of DPP-IV inhibitors.

Authors:  J J Holst; C F Deacon
Journal:  Diabetologia       Date:  2005-03-10       Impact factor: 10.122

3.  The therapeutic actions of DPP-IV inhibition are not mediated by glucagon-like peptide-1.

Authors:  M A Nauck; A El-Ouaghlidi
Journal:  Diabetologia       Date:  2005-03-11       Impact factor: 10.122

Review 4.  Extrapancreatic effects of GIP and GLP-1.

Authors:  A Vella; R A Rizza
Journal:  Horm Metab Res       Date:  2004 Nov-Dec       Impact factor: 2.936

5.  Both subcutaneously and intravenously administered glucagon-like peptide I are rapidly degraded from the NH2-terminus in type II diabetic patients and in healthy subjects.

Authors:  C F Deacon; M A Nauck; M Toft-Nielsen; L Pridal; B Willms; J J Holst
Journal:  Diabetes       Date:  1995-09       Impact factor: 9.461

6.  Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study.

Authors:  Mette Zander; Sten Madsbad; Jan Lysgaard Madsen; Jens Juul Holst
Journal:  Lancet       Date:  2002-03-09       Impact factor: 79.321

Review 7.  The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes.

Authors:  Daniel J Drucker; Michael A Nauck
Journal:  Lancet       Date:  2006-11-11       Impact factor: 79.321

8.  Proglucagon processing in porcine and human pancreas.

Authors:  J J Holst; M Bersani; A H Johnsen; H Kofod; B Hartmann; C Orskov
Journal:  J Biol Chem       Date:  1994-07-22       Impact factor: 5.157

9.  Double incretin receptor knockout (DIRKO) mice reveal an essential role for the enteroinsular axis in transducing the glucoregulatory actions of DPP-IV inhibitors.

Authors:  Tanya Hansotia; Laurie L Baggio; Dominique Delmeire; Simon A Hinke; Yuichiro Yamada; Katsushi Tsukiyama; Yutaka Seino; Jens J Holst; Frans Schuit; D J Drucker
Journal:  Diabetes       Date:  2004-05       Impact factor: 9.461

10.  Pathogenesis of age-related glucose intolerance in man: insulin resistance and decreased beta-cell function.

Authors:  M Chen; R N Bergman; G Pacini; D Porte
Journal:  J Clin Endocrinol Metab       Date:  1985-01       Impact factor: 5.958
View more
  17 in total

1.  Glucose metabolism during rotational shift-work in healthcare workers.

Authors:  Anu Sharma; Marcello C Laurenti; Chiara Dalla Man; Ron T Varghese; Claudio Cobelli; Robert A Rizza; Aleksey Matveyenko; Adrian Vella
Journal:  Diabetologia       Date:  2017-05-27       Impact factor: 10.122

2.  In vitro and in vivo study of inhibitory potentials of α-glucosidase and acetylcholinesterase and biochemical profiling of M. charantia in alloxan-induced diabetic rat models.

Authors:  Fatma Hussain; Javaria Hafeez; Amany S Khalifa; Muhammad Naeem; Tayyab Ali; Emad M Eed
Journal:  Am J Transl Res       Date:  2022-06-15       Impact factor: 3.940

Review 3.  The Role of Endometrial Stem/Progenitor Cells in Recurrent Reproductive Failure.

Authors:  Hannan Al-Lamee; Christopher J Hill; Florence Turner; Thuan Phan; Andrew J Drakeley; Dharani K Hapangama; Nicola Tempest
Journal:  J Pers Med       Date:  2022-05-11

Review 4.  Pathophysiology of prediabetes and treatment implications for the prevention of type 2 diabetes mellitus.

Authors:  Michael Bergman
Journal:  Endocrine       Date:  2012-11-07       Impact factor: 3.633

5.  Culturally based pre-Ramadan education increased benefits and reduced hazards of Ramadan fasting for type 2 diabetic patients.

Authors:  Inass Shaltout; Abir Zakaria; Amr Mahmoud Abdelwahab; AbdelKhalek Hamed; Nehal Hamdy Elsaid; Mazen Ahmed Attia
Journal:  J Diabetes Metab Disord       Date:  2020-01-30

Review 6.  Dipeptidyl peptidase-4 inhibitors: Novel mechanism of actions.

Authors:  Awadhesh Kumar Singh
Journal:  Indian J Endocrinol Metab       Date:  2014-11

7.  Dipeptidyl Peptidase-4 inhibitors use in type II diabetic patients in a tertiary hospital.

Authors:  Woh Yon Mak; Jivanraj R Nagarajah; Hannah Abdul Halim; Anitha Ramadas; Zulsairi Mohd Pauzi; Lay Ting Pee; Nirmala Jagan
Journal:  J Pharm Policy Pract       Date:  2020-06-18

Review 8.  Neuroprotective Properties of Linagliptin: Focus on Biochemical Mechanisms in Cerebral Ischemia, Vascular Dysfunction and Certain Neurodegenerative Diseases.

Authors:  Michał Wiciński; Karol Górski; Maciej Walczak; Eryk Wódkiewicz; Maciej Słupski; Katarzyna Pawlak-Osińska; Bartosz Malinowski
Journal:  Int J Mol Sci       Date:  2019-08-20       Impact factor: 5.923

9.  Risk of heart failure hospitalization among users of dipeptidyl peptidase-4 inhibitors compared to glucagon-like peptide-1 receptor agonists.

Authors:  Ghadeer K Dawwas; Steven M Smith; Haesuk Park
Journal:  Cardiovasc Diabetol       Date:  2018-07-17       Impact factor: 9.951

Review 10.  Effects of antidiabetic drugs on epicardial fat.

Authors:  Eleni Xourgia; Athanasia Papazafiropoulou; Andreas Melidonis
Journal:  World J Diabetes       Date:  2018-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.